Sign in

Patrick N. Harter

@tnonc-harter-lab.bsky.social
162 followers 82 following 8 posts

Neuropathologist Ludwig-Maximilians-University Munich, Germany Translational NeuroONCology Group @LMU_Muenchen @LMU_Uniklinikum #glioma #melanoma #brainmetastasis

PostsRepliesMedia
Patrick N. Harter @tnonc-harter-lab.bsky.social · 29/05/2025
Looking forward to Maastricht 2025 ecnp2025.nl
010
Patrick N. Harter @tnonc-harter-lab.bsky.social · 30/03/2025
www.uni-muenster.de/Ejournals/in... Nice overview of Top Ten Papers in Neurooncology 2024 in #freeneuropathology and proud that our work on Brain metastasis is included! Thanks to all the fantastic collaborators and to #freeneuropathology
uni-muenster.de
View of Neurooncology: 2025 update | Free Neuropathology
030
Patrick N. Harter @tnonc-harter-lab.bsky.social · 08/02/2025
In some aspects it is already 5 past 12 but anyway Never too Late to adjust the clockwork. This is a fantastic Initiative by many great colleagues and Friends! 💪🏽 Thank you!!! Check out aufstehenfuerdemokratie.de
aufstehenfuerdemokratie.de
Aufstehen für Demokratie – Fakten sind das Rückgrat unserer Demokratie
1102
Reposted by Patrick N. Harter
Pia S. Zeiner @piazeiner.bsky.social · 29/01/2025
Excited to collaborate with @hoheyn.bsky.social, @jcnietos.bsky.social, @paulanietog.bsky.social & team on leptomeningeal metastatic disease - a key challenge in #NeuroOncology. Our study reveals unique immune responses in CSF, highlighting CSF liquid biopsy’s potential to guide CNS tumor therapies.
1113
Patrick N. Harter @tnonc-harter-lab.bsky.social · 17/01/2025
www.cell.com/cancer-cell/... CD74 !!! This is Colon and this is what we found in Brain metastasis some years ago with @piazeiner.bsky.social 👍🏽 actaneurocomms.biomedcentral.com/articles/10....
actaneurocomms.biomedcentral.com
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival - Acta Neuropathologica Communications
Despite multidisciplinary local and systemic therapeutic approaches, the prognosis for most patients with brain metastases is still dismal. The role of adaptive and innate anti-tumor response includin...
081
Patrick N. Harter @tnonc-harter-lab.bsky.social · 11/01/2025
PhD position translational program of clinical study on glioblastoma (experimental/computational) supported by DKH. Lively research community and supervised by Prof. Kristian Unger, AI-Professor at LMU Munich and myself. Looking forward to your applications ! euraxess.ec.europa.eu/jobs/306276
euraxess.ec.europa.eu
PhD position translational program of clinical study on glioblastoma (experimental/computational)
The experimental and computational doctoral position (3 years, TV-L E13 65%) is located in the AI-assisted therapy decisions in oncology group (Prof.
160
Patrick N. Harter @tnonc-harter-lab.bsky.social · 07/01/2025
www.nature.com/articles/s41... Overcoming ICI resistance. Great translation of basic research. Congratulations to all authors and special thanks to Jörg Wischhusen for his dedication to this project!
nature.com
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - Nature
A study reporting the results of a clinical trial co-administering the GDF-15-blocking antibody visugromab with the anti-PD-1 antibody nivolumab demonstrates that neutralizing GDF-15 can overcome resi...
040
Patrick N. Harter @tnonc-harter-lab.bsky.social · 20/11/2024
actaneurocomms.biomedcentral.com/articles/10.... Somatic Copy Number Alterations in CSF cfDNA. Great collaboration lead by Pia S. Zeiner and Team @loewe-fci.bsky.social
actaneurocomms.biomedcentral.com
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients - Acta Neuropathologica Communications
The gold standard for precise diagnostic classification of brain tumors requires tissue sampling, which carries relevant procedural risks. Brain biopsies often have limited sensitivity and fail to add...
041